Brief: Agile Therapeutics Reports Third Quarter 2022 Financial Results
Nov 7 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* AGILE THERAPEUTICS INC - QTRLY REVENUE $3 MILLION VERSUS
$1.3
MILLION
* AGILE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.53
Source text for Eikon: ID:nGNX9zz3gW
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt